Skip to main content
Back to Flybridge

Flybridge's Biotechnology Portfolio

Browse 8 Biotechnology companies funded by Flybridge. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
8
Total Funding in Biotechnology
$75.0M

Biotechnology Portfolio Companies (8)

Export
BiotechnologyPetVeterinary

Vetmab Biosciences is a veterinary company that currently operates in stealth mode.

San Diego, United States
August 2022
$2.0M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyChemical EngineeringFood and BeverageFood ProcessingManufacturingWaste Management

Hyfé turns food waste into chemicals that maximize profits for food processors while allowing the world to make products without petroleum.

Chicago, United States
June 2023
$9.0M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Engage Bio develops non-viral DNA medicines for genetic and therapeutic applications.

San Carlos, United States
May 2022
Seed

Founder Contacts

30,000+ verified contacts

Alternative ProteinBiotechnologyChemicalHealth Care

Nalu Bio is a biotechnology company that focuses on a science and data-driven approach to cannabanoid biology.

San Francisco, United States
March 2025
Non-equity Assistance

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceutical

AltrixBio is a pharmaceutical company focused on oral drug that replicates the metabolic success of bariatric surgery.

Cambridge, United States
May 2025
$1.2M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyGenetics

Pow.bio provides a genetically engineered solution for fermentation scientists.

Berkeley, United States
October 2023
$9.5M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife Science

BoobyBiome uses specialist expertise and research to develop a probiotic supplement for infants with compromised microbiomes.

London, United Kingdom
September 2025
$3.4M
Seed

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceMedical

Proscia develops digital pathology software designed to help laboratories and life sciences organizations manage and analyze pathology data.

Philadelphia, United States
March 2025
$50.0M
Series D

Founder Contacts

30,000+ verified contacts

Explore Flybridge's Full Portfolio

View all companies funded by Flybridge across every industry and funding stage.

View Full Flybridge Portfolio